Virtual alcohol detox and recovery platform Clean Slate Clinic has raised $4.3 million ahead of plans for a $10m Series A.
Impact investor Giant Leap and an existing backer Scale Investors backed the $2.8m convertible note. Existing investor Australian Medical Angels also supported the startup with a $1.5m debt facility.
Founded in 2020, Clean Slate is a social enterprise with more than 3000 clients helping them detox at home from alcohol, stimulant, or cannabis.
Clean Slate is now looking to raise $10m in Series A for UK growth and expansion into other markets in 2027.
Cofounder Chris Davis, a GP, said while 1.4 million drink at levels requiring specialist care, only one in four people with alcohol dependence ever seek treatment, and even then it can take nearly 20 years to ask for help.
“Alcohol is the most common drug presentation in the Australian health system, yet safe, clinician-led detox at home has been virtually non-existent,” he said.
Get the best of Startup Daily straight to your inbox
Want to know the latest in startup news? Subscribe to our daily news and analysis coverage on what’s happening to ANZ startups, investors and the broader ecosystem. And best of all, it’s FREE!
By continuing, you agree to our Terms & Conditions and Privacy Policy.
“For years, I watched people cycle through crisis because community care simply didn’t exist at scale. Clean Slate changes that by giving people access to medical care at home when they are ready to seek help.”
Giant Leap partner Rachel Yang said stigma and outdated treatment models mean many people delay or avoid seeking care, so Clean Slate offers a better model.
“What’s compelling is not just the accessibility and clinical impact, but the commercial validation,” she said.
“The company has achieved strong year-on-year growth and secured reimbursement coverage across the majority of Australia’s private health insurers. It’s a rare example of a solution that is better for patients, payers and the healthcare system as a whole.”
